99% Savings - Buy Just @1 Rs X
Peakhale SF 50 Mcg/250 Mcg Respicap is a prescription medicine that is available as a Respicaps. Secondary and off-label uses of Peakhale SF 50 Mcg/250 Mcg Respicap have also been mentioned below.
The right dosage of Peakhale SF 50 Mcg/250 Mcg Respicap depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Peakhale SF 50 Mcg/250 Mcg Respicap include Shortness of Breath, Throat Irritation, Nosebleed. Apart from the aforementioned side effects, Peakhale SF 50 Mcg/250 Mcg Respicap can also lead to other problems, which have been listed below. Normally, these side effects of Peakhale SF 50 Mcg/250 Mcg Respicap are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Peakhale SF 50 Mcg/250 Mcg Respicap's effect is Moderate during pregnancy and Mild for lactating mothers. In addition, Peakhale SF 50 Mcg/250 Mcg Respicap's effects on the liver, heart and kidney are discussed below in the Peakhale SF 50 Mcg/250 Mcg Respicap related warnings section.
Other conditions have been mentioned below in the Peakhale SF 50 Mcg/250 Mcg Respicap contraindications section.
Additionally, Peakhale SF 50 Mcg/250 Mcg Respicap may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Peakhale SF 50 Mcg/250 Mcg Respicap is safe while driving, and is addiction.
Peakhale SF 50 Mcg/250 Mcg Respicap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Peakhale SF 50 Mcg/250 Mcg Respicap safe for pregnant women?
Peakhale Sf can have harmful effects in pregnant women. If you experience any discomfort after using Peakhale Sf, then discontinue the use and take your doctor's advice.
Is the use of Peakhale SF 50 Mcg/250 Mcg Respicap safe during breastfeeding?
Peakhale Sf has been seen to have minimal side effects on breastfeeding women.
What is the effect of Peakhale SF 50 Mcg/250 Mcg Respicap on the Kidneys?
Using Peakhale Sf does not have any harmful effects on kidneys.
What is the effect of Peakhale SF 50 Mcg/250 Mcg Respicap on the Liver?
There may be an adverse effect on the liver after taking Peakhale Sf. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Peakhale SF 50 Mcg/250 Mcg Respicap on the Heart?
There may be an adverse effect on the heart after taking Peakhale Sf. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Peakhale SF 50 Mcg/250 Mcg Respicap unless your doctor advises you to do so -
Is this Peakhale SF 50 Mcg/250 Mcg Respicap habit forming or addictive?
Forming a habit of Peakhale SF 50 Mcg/250 Mcg Respicap has not been reported.
Interaction between Food and Peakhale SF 50 Mcg/250 Mcg Respicap
There is no information on the effects of taking Peakhale SF 50 Mcg/250 Mcg Respicap with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Peakhale SF 50 Mcg/250 Mcg Respicap
Due to lack of research, there is no information about the side effects of taking Peakhale SF 50 Mcg/250 Mcg Respicap with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359